世界の全身性コルチコステロイド市場予測 2023年-2029年

【英語タイトル】Global Systemic Corticosteroids Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC00138)・商品コード:LP23DC00138
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:105
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の全身性コルチコステロイド市場」は、過去の販売実績から2022年の世界の全身性コルチコステロイドの総販売量を検討し、2023年から2029年の予測される全身性コルチコステロイドの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の全身性コルチコステロイドの市場規模を掲載し、XXX百万米ドル規模の世界の全身性コルチコステロイド市場の詳細な分析を提供します。本インサイトレポートは、世界の全身性コルチコステロイド業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の全身性コルチコステロイド市場における各社の独自のポジションをより深く理解するために、全身性コルチコステロイド製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の全身性コルチコステロイド市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。全身性コルチコステロイドの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。全身性コルチコステロイドの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。全身性コルチコステロイドのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

全身性コルチコステロイドの世界主要メーカーとしては、Pfizer、 Sandoz、 Hikma Pharmaceuticals、 Teva Pharmaceutical、 Lupin、 Zydus Pharmaceuticals、 Sinopharm Group Rongsheng Pharmaceutical、 Tianjin Tianyao Pharmaceuticals、 Liaoning Haisco Pharmaceutical、 Nang Kuang Pharmaceutical、 Chongqing Huapont Pharmaceutical、 Zhejiang Xianju Pharmaceutical、 Fuan Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の全身性コルチコステロイド市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では全身性コルチコステロイド市場をセグメンテーションし、種類別 (メチルプレドニゾロン、プレドニゾロン、ベタメタゾン、デキサメタゾン、プレドニゾン、トリアムシノロンアセトニド、ヒドロコルチゾン、その他)、用途別 (病院、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:メチルプレドニゾロン、プレドニゾロン、ベタメタゾン、デキサメタゾン、プレドニゾン、トリアムシノロンアセトニド、ヒドロコルチゾン、その他

・用途別区分:病院、薬局、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の全身性コルチコステロイド市場の10年間の市場状況・展望は?
・世界および地域別に見た全身性コルチコステロイド市場成長の要因は何か?
・全身性コルチコステロイドの市場機会はエンドマーケットの規模によってどのように変化するのか?
・全身性コルチコステロイドのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:全身性コルチコステロイドの年間販売量2018-2029、地域別現状・将来分析
・全身性コルチコステロイドの種類別セグメント:メチルプレドニゾロン、プレドニゾロン、ベタメタゾン、デキサメタゾン、プレドニゾン、トリアムシノロンアセトニド、ヒドロコルチゾン、その他
・全身性コルチコステロイドの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・全身性コルチコステロイドの用途別セグメント:病院、薬局、その他
・全身性コルチコステロイドの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の全身性コルチコステロイド市場
・企業別のグローバル全身性コルチコステロイド市場データ:2018-2023年の年間販売量、市場シェア
・企業別の全身性コルチコステロイドの年間売上:2018-2023年の売上、市場シェア
・企業別の全身性コルチコステロイド販売価格
・主要企業の全身性コルチコステロイド生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

全身性コルチコステロイドの地域別レビュー
・地域別の全身性コルチコステロイド市場規模2018-2023:年間販売量、売上
・主要国別の全身性コルチコステロイド市場規模2018-2023:年間販売量、売上
・南北アメリカの全身性コルチコステロイド販売の成長
・アジア太平洋の全身性コルチコステロイド販売の成長
・ヨーロッパの全身性コルチコステロイド販売の成長
・中東・アフリカの全身性コルチコステロイド販売の成長

南北アメリカ市場
・南北アメリカの国別の全身性コルチコステロイド販売量、売上(2018-2023)
・南北アメリカの全身性コルチコステロイドの種類別販売量
・南北アメリカの全身性コルチコステロイドの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の全身性コルチコステロイド販売量、売上(2018-2023)
・アジア太平洋の全身性コルチコステロイドの種類別販売量
・アジア太平洋の全身性コルチコステロイドの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の全身性コルチコステロイド販売量、売上(2018-2023)
・ヨーロッパの全身性コルチコステロイドの種類別販売量
・ヨーロッパの全身性コルチコステロイドの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の全身性コルチコステロイド販売量、売上(2018-2023)
・中東・アフリカの全身性コルチコステロイドの種類別販売量
・中東・アフリカの全身性コルチコステロイドの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・全身性コルチコステロイドの製造コスト構造分析
・全身性コルチコステロイドの製造プロセス分析
・全身性コルチコステロイドの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・全身性コルチコステロイドの主要なグローバル販売業者
・全身性コルチコステロイドの主要なグローバル顧客

地域別の全身性コルチコステロイド市場予測レビュー
・地域別の全身性コルチコステロイド市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・全身性コルチコステロイドの種類別市場規模予測
・全身性コルチコステロイドの用途別市場規模予測

主要企業分析
Pfizer、 Sandoz、 Hikma Pharmaceuticals、 Teva Pharmaceutical、 Lupin、 Zydus Pharmaceuticals、 Sinopharm Group Rongsheng Pharmaceutical、 Tianjin Tianyao Pharmaceuticals、 Liaoning Haisco Pharmaceutical、 Nang Kuang Pharmaceutical、 Chongqing Huapont Pharmaceutical、 Zhejiang Xianju Pharmaceutical、 Fuan Pharmaceutical
・企業情報
・全身性コルチコステロイド製品
・全身性コルチコステロイド販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Systemic Corticosteroids market size is projected to grow from US$ 14920 million in 2022 to US$ 26950 million in 2029; it is expected to grow at a CAGR of 8.8% from 2023 to 2029.
United States market for Systemic Corticosteroids is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Systemic Corticosteroids is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Systemic Corticosteroids is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Systemic Corticosteroids players cover Pfizer, Sandoz, Hikma Pharmaceuticals, Teva Pharmaceutical, Lupin, Zydus Pharmaceuticals, Sinopharm Group Rongsheng Pharmaceutical, Tianjin Tianyao Pharmaceuticals and Liaoning Haisco Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Systemic corticosteroids are medications that contain synthetic versions of the hormones produced by the adrenal glands. They are used to treat a variety of medical conditions, including autoimmune disorders, asthma, allergies, and skin conditions such as eczema and psoriasis.
LPI (LP Information)’ newest research report, the “Systemic Corticosteroids Industry Forecast” looks at past sales and reviews total world Systemic Corticosteroids sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Corticosteroids sales for 2023 through 2029. With Systemic Corticosteroids sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Corticosteroids industry.
This Insight Report provides a comprehensive analysis of the global Systemic Corticosteroids landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Corticosteroids portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Corticosteroids market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Corticosteroids and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Corticosteroids.
This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Corticosteroids market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Methylprednisolone
Prednisolone
Betamethasone
Dexamethasone
Prednisone
Triamcinolone Acetonide
Hydrocortisone
Other
Segmentation by application
Hospital
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Sandoz
Hikma Pharmaceuticals
Teva Pharmaceutical
Lupin
Zydus Pharmaceuticals
Sinopharm Group Rongsheng Pharmaceutical
Tianjin Tianyao Pharmaceuticals
Liaoning Haisco Pharmaceutical
Nang Kuang Pharmaceutical
Chongqing Huapont Pharmaceutical
Zhejiang Xianju Pharmaceutical
Fuan Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Systemic Corticosteroids market?
What factors are driving Systemic Corticosteroids market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Systemic Corticosteroids market opportunities vary by end market size?
How does Systemic Corticosteroids break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Systemic Corticosteroids Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Systemic Corticosteroids by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Systemic Corticosteroids by Country/Region, 2018, 2022 & 2029
2.2 Systemic Corticosteroids Segment by Type
2.2.1 Methylprednisolone
2.2.2 Prednisolone
2.2.3 Betamethasone
2.2.4 Dexamethasone
2.2.5 Prednisone
2.2.6 Triamcinolone Acetonide
2.2.7 Hydrocortisone
2.2.8 Other
2.3 Systemic Corticosteroids Sales by Type
2.3.1 Global Systemic Corticosteroids Sales Market Share by Type (2018-2023)
2.3.2 Global Systemic Corticosteroids Revenue and Market Share by Type (2018-2023)
2.3.3 Global Systemic Corticosteroids Sale Price by Type (2018-2023)
2.4 Systemic Corticosteroids Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Systemic Corticosteroids Sales by Application
2.5.1 Global Systemic Corticosteroids Sale Market Share by Application (2018-2023)
2.5.2 Global Systemic Corticosteroids Revenue and Market Share by Application (2018-2023)
2.5.3 Global Systemic Corticosteroids Sale Price by Application (2018-2023)
3 Global Systemic Corticosteroids by Company
3.1 Global Systemic Corticosteroids Breakdown Data by Company
3.1.1 Global Systemic Corticosteroids Annual Sales by Company (2018-2023)
3.1.2 Global Systemic Corticosteroids Sales Market Share by Company (2018-2023)
3.2 Global Systemic Corticosteroids Annual Revenue by Company (2018-2023)
3.2.1 Global Systemic Corticosteroids Revenue by Company (2018-2023)
3.2.2 Global Systemic Corticosteroids Revenue Market Share by Company (2018-2023)
3.3 Global Systemic Corticosteroids Sale Price by Company
3.4 Key Manufacturers Systemic Corticosteroids Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Systemic Corticosteroids Product Location Distribution
3.4.2 Players Systemic Corticosteroids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Systemic Corticosteroids by Geographic Region
4.1 World Historic Systemic Corticosteroids Market Size by Geographic Region (2018-2023)
4.1.1 Global Systemic Corticosteroids Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Systemic Corticosteroids Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Systemic Corticosteroids Market Size by Country/Region (2018-2023)
4.2.1 Global Systemic Corticosteroids Annual Sales by Country/Region (2018-2023)
4.2.2 Global Systemic Corticosteroids Annual Revenue by Country/Region (2018-2023)
4.3 Americas Systemic Corticosteroids Sales Growth
4.4 APAC Systemic Corticosteroids Sales Growth
4.5 Europe Systemic Corticosteroids Sales Growth
4.6 Middle East & Africa Systemic Corticosteroids Sales Growth
5 Americas
5.1 Americas Systemic Corticosteroids Sales by Country
5.1.1 Americas Systemic Corticosteroids Sales by Country (2018-2023)
5.1.2 Americas Systemic Corticosteroids Revenue by Country (2018-2023)
5.2 Americas Systemic Corticosteroids Sales by Type
5.3 Americas Systemic Corticosteroids Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Systemic Corticosteroids Sales by Region
6.1.1 APAC Systemic Corticosteroids Sales by Region (2018-2023)
6.1.2 APAC Systemic Corticosteroids Revenue by Region (2018-2023)
6.2 APAC Systemic Corticosteroids Sales by Type
6.3 APAC Systemic Corticosteroids Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Systemic Corticosteroids by Country
7.1.1 Europe Systemic Corticosteroids Sales by Country (2018-2023)
7.1.2 Europe Systemic Corticosteroids Revenue by Country (2018-2023)
7.2 Europe Systemic Corticosteroids Sales by Type
7.3 Europe Systemic Corticosteroids Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Systemic Corticosteroids by Country
8.1.1 Middle East & Africa Systemic Corticosteroids Sales by Country (2018-2023)
8.1.2 Middle East & Africa Systemic Corticosteroids Revenue by Country (2018-2023)
8.2 Middle East & Africa Systemic Corticosteroids Sales by Type
8.3 Middle East & Africa Systemic Corticosteroids Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Systemic Corticosteroids
10.3 Manufacturing Process Analysis of Systemic Corticosteroids
10.4 Industry Chain Structure of Systemic Corticosteroids
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Systemic Corticosteroids Distributors
11.3 Systemic Corticosteroids Customer
12 World Forecast Review for Systemic Corticosteroids by Geographic Region
12.1 Global Systemic Corticosteroids Market Size Forecast by Region
12.1.1 Global Systemic Corticosteroids Forecast by Region (2024-2029)
12.1.2 Global Systemic Corticosteroids Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Systemic Corticosteroids Forecast by Type
12.7 Global Systemic Corticosteroids Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Systemic Corticosteroids Product Portfolios and Specifications
13.1.3 Pfizer Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Systemic Corticosteroids Product Portfolios and Specifications
13.2.3 Sandoz Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Systemic Corticosteroids Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Information
13.4.2 Teva Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Pharmaceutical Main Business Overview
13.4.5 Teva Pharmaceutical Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Systemic Corticosteroids Product Portfolios and Specifications
13.5.3 Lupin Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Zydus Pharmaceuticals
13.6.1 Zydus Pharmaceuticals Company Information
13.6.2 Zydus Pharmaceuticals Systemic Corticosteroids Product Portfolios and Specifications
13.6.3 Zydus Pharmaceuticals Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zydus Pharmaceuticals Main Business Overview
13.6.5 Zydus Pharmaceuticals Latest Developments
13.7 Sinopharm Group Rongsheng Pharmaceutical
13.7.1 Sinopharm Group Rongsheng Pharmaceutical Company Information
13.7.2 Sinopharm Group Rongsheng Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.7.3 Sinopharm Group Rongsheng Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sinopharm Group Rongsheng Pharmaceutical Main Business Overview
13.7.5 Sinopharm Group Rongsheng Pharmaceutical Latest Developments
13.8 Tianjin Tianyao Pharmaceuticals
13.8.1 Tianjin Tianyao Pharmaceuticals Company Information
13.8.2 Tianjin Tianyao Pharmaceuticals Systemic Corticosteroids Product Portfolios and Specifications
13.8.3 Tianjin Tianyao Pharmaceuticals Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Tianjin Tianyao Pharmaceuticals Main Business Overview
13.8.5 Tianjin Tianyao Pharmaceuticals Latest Developments
13.9 Liaoning Haisco Pharmaceutical
13.9.1 Liaoning Haisco Pharmaceutical Company Information
13.9.2 Liaoning Haisco Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.9.3 Liaoning Haisco Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Liaoning Haisco Pharmaceutical Main Business Overview
13.9.5 Liaoning Haisco Pharmaceutical Latest Developments
13.10 Nang Kuang Pharmaceutical
13.10.1 Nang Kuang Pharmaceutical Company Information
13.10.2 Nang Kuang Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.10.3 Nang Kuang Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nang Kuang Pharmaceutical Main Business Overview
13.10.5 Nang Kuang Pharmaceutical Latest Developments
13.11 Chongqing Huapont Pharmaceutical
13.11.1 Chongqing Huapont Pharmaceutical Company Information
13.11.2 Chongqing Huapont Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.11.3 Chongqing Huapont Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Chongqing Huapont Pharmaceutical Main Business Overview
13.11.5 Chongqing Huapont Pharmaceutical Latest Developments
13.12 Zhejiang Xianju Pharmaceutical
13.12.1 Zhejiang Xianju Pharmaceutical Company Information
13.12.2 Zhejiang Xianju Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.12.3 Zhejiang Xianju Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.12.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.13 Fuan Pharmaceutical
13.13.1 Fuan Pharmaceutical Company Information
13.13.2 Fuan Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
13.13.3 Fuan Pharmaceutical Systemic Corticosteroids Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Fuan Pharmaceutical Main Business Overview
13.13.5 Fuan Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Systemic Corticosteroids Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Systemic Corticosteroids Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Methylprednisolone
Table 4. Major Players of Prednisolone
Table 5. Major Players of Betamethasone
Table 6. Major Players of Dexamethasone
Table 7. Major Players of Prednisone
Table 8. Major Players of Triamcinolone Acetonide
Table 9. Major Players of Hydrocortisone
Table 10. Major Players of Other
Table 11. Global Systemic Corticosteroids Sales by Type (2018-2023) & (K Units)
Table 12. Global Systemic Corticosteroids Sales Market Share by Type (2018-2023)
Table 13. Global Systemic Corticosteroids Revenue by Type (2018-2023) & ($ million)
Table 14. Global Systemic Corticosteroids Revenue Market Share by Type (2018-2023)
Table 15. Global Systemic Corticosteroids Sale Price by Type (2018-2023) & (US$/Unit)
Table 16. Global Systemic Corticosteroids Sales by Application (2018-2023) & (K Units)
Table 17. Global Systemic Corticosteroids Sales Market Share by Application (2018-2023)
Table 18. Global Systemic Corticosteroids Revenue by Application (2018-2023)
Table 19. Global Systemic Corticosteroids Revenue Market Share by Application (2018-2023)
Table 20. Global Systemic Corticosteroids Sale Price by Application (2018-2023) & (US$/Unit)
Table 21. Global Systemic Corticosteroids Sales by Company (2018-2023) & (K Units)
Table 22. Global Systemic Corticosteroids Sales Market Share by Company (2018-2023)
Table 23. Global Systemic Corticosteroids Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Systemic Corticosteroids Revenue Market Share by Company (2018-2023)
Table 25. Global Systemic Corticosteroids Sale Price by Company (2018-2023) & (US$/Unit)
Table 26. Key Manufacturers Systemic Corticosteroids Producing Area Distribution and Sales Area
Table 27. Players Systemic Corticosteroids Products Offered
Table 28. Systemic Corticosteroids Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Systemic Corticosteroids Sales by Geographic Region (2018-2023) & (K Units)
Table 32. Global Systemic Corticosteroids Sales Market Share Geographic Region (2018-2023)
Table 33. Global Systemic Corticosteroids Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Systemic Corticosteroids Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Systemic Corticosteroids Sales by Country/Region (2018-2023) & (K Units)
Table 36. Global Systemic Corticosteroids Sales Market Share by Country/Region (2018-2023)
Table 37. Global Systemic Corticosteroids Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Systemic Corticosteroids Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Systemic Corticosteroids Sales by Country (2018-2023) & (K Units)
Table 40. Americas Systemic Corticosteroids Sales Market Share by Country (2018-2023)
Table 41. Americas Systemic Corticosteroids Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Systemic Corticosteroids Revenue Market Share by Country (2018-2023)
Table 43. Americas Systemic Corticosteroids Sales by Type (2018-2023) & (K Units)
Table 44. Americas Systemic Corticosteroids Sales by Application (2018-2023) & (K Units)
Table 45. APAC Systemic Corticosteroids Sales by Region (2018-2023) & (K Units)
Table 46. APAC Systemic Corticosteroids Sales Market Share by Region (2018-2023)
Table 47. APAC Systemic Corticosteroids Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Systemic Corticosteroids Revenue Market Share by Region (2018-2023)
Table 49. APAC Systemic Corticosteroids Sales by Type (2018-2023) & (K Units)
Table 50. APAC Systemic Corticosteroids Sales by Application (2018-2023) & (K Units)
Table 51. Europe Systemic Corticosteroids Sales by Country (2018-2023) & (K Units)
Table 52. Europe Systemic Corticosteroids Sales Market Share by Country (2018-2023)
Table 53. Europe Systemic Corticosteroids Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Systemic Corticosteroids Revenue Market Share by Country (2018-2023)
Table 55. Europe Systemic Corticosteroids Sales by Type (2018-2023) & (K Units)
Table 56. Europe Systemic Corticosteroids Sales by Application (2018-2023) & (K Units)
Table 57. Middle East & Africa Systemic Corticosteroids Sales by Country (2018-2023) & (K Units)
Table 58. Middle East & Africa Systemic Corticosteroids Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Systemic Corticosteroids Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Systemic Corticosteroids Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Systemic Corticosteroids Sales by Type (2018-2023) & (K Units)
Table 62. Middle East & Africa Systemic Corticosteroids Sales by Application (2018-2023) & (K Units)
Table 63. Key Market Drivers & Growth Opportunities of Systemic Corticosteroids
Table 64. Key Market Challenges & Risks of Systemic Corticosteroids
Table 65. Key Industry Trends of Systemic Corticosteroids
Table 66. Systemic Corticosteroids Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Systemic Corticosteroids Distributors List
Table 69. Systemic Corticosteroids Customer List
Table 70. Global Systemic Corticosteroids Sales Forecast by Region (2024-2029) & (K Units)
Table 71. Global Systemic Corticosteroids Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Systemic Corticosteroids Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Americas Systemic Corticosteroids Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Systemic Corticosteroids Sales Forecast by Region (2024-2029) & (K Units)
Table 75. APAC Systemic Corticosteroids Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Systemic Corticosteroids Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Europe Systemic Corticosteroids Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Systemic Corticosteroids Sales Forecast by Country (2024-2029) & (K Units)
Table 79. Middle East & Africa Systemic Corticosteroids Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Systemic Corticosteroids Sales Forecast by Type (2024-2029) & (K Units)
Table 81. Global Systemic Corticosteroids Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Systemic Corticosteroids Sales Forecast by Application (2024-2029) & (K Units)
Table 83. Global Systemic Corticosteroids Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Pfizer Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Systemic Corticosteroids Product Portfolios and Specifications
Table 86. Pfizer Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Sandoz Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 90. Sandoz Systemic Corticosteroids Product Portfolios and Specifications
Table 91. Sandoz Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Sandoz Main Business
Table 93. Sandoz Latest Developments
Table 94. Hikma Pharmaceuticals Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 95. Hikma Pharmaceuticals Systemic Corticosteroids Product Portfolios and Specifications
Table 96. Hikma Pharmaceuticals Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Hikma Pharmaceuticals Main Business
Table 98. Hikma Pharmaceuticals Latest Developments
Table 99. Teva Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 101. Teva Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Teva Pharmaceutical Main Business
Table 103. Teva Pharmaceutical Latest Developments
Table 104. Lupin Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 105. Lupin Systemic Corticosteroids Product Portfolios and Specifications
Table 106. Lupin Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Lupin Main Business
Table 108. Lupin Latest Developments
Table 109. Zydus Pharmaceuticals Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 110. Zydus Pharmaceuticals Systemic Corticosteroids Product Portfolios and Specifications
Table 111. Zydus Pharmaceuticals Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Zydus Pharmaceuticals Main Business
Table 113. Zydus Pharmaceuticals Latest Developments
Table 114. Sinopharm Group Rongsheng Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 115. Sinopharm Group Rongsheng Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 116. Sinopharm Group Rongsheng Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Sinopharm Group Rongsheng Pharmaceutical Main Business
Table 118. Sinopharm Group Rongsheng Pharmaceutical Latest Developments
Table 119. Tianjin Tianyao Pharmaceuticals Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 120. Tianjin Tianyao Pharmaceuticals Systemic Corticosteroids Product Portfolios and Specifications
Table 121. Tianjin Tianyao Pharmaceuticals Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Tianjin Tianyao Pharmaceuticals Main Business
Table 123. Tianjin Tianyao Pharmaceuticals Latest Developments
Table 124. Liaoning Haisco Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 125. Liaoning Haisco Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 126. Liaoning Haisco Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Liaoning Haisco Pharmaceutical Main Business
Table 128. Liaoning Haisco Pharmaceutical Latest Developments
Table 129. Nang Kuang Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 130. Nang Kuang Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 131. Nang Kuang Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Nang Kuang Pharmaceutical Main Business
Table 133. Nang Kuang Pharmaceutical Latest Developments
Table 134. Chongqing Huapont Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 135. Chongqing Huapont Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 136. Chongqing Huapont Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Chongqing Huapont Pharmaceutical Main Business
Table 138. Chongqing Huapont Pharmaceutical Latest Developments
Table 139. Zhejiang Xianju Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 140. Zhejiang Xianju Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 141. Zhejiang Xianju Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Zhejiang Xianju Pharmaceutical Main Business
Table 143. Zhejiang Xianju Pharmaceutical Latest Developments
Table 144. Fuan Pharmaceutical Basic Information, Systemic Corticosteroids Manufacturing Base, Sales Area and Its Competitors
Table 145. Fuan Pharmaceutical Systemic Corticosteroids Product Portfolios and Specifications
Table 146. Fuan Pharmaceutical Systemic Corticosteroids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Fuan Pharmaceutical Main Business
Table 148. Fuan Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Systemic Corticosteroids
Figure 2. Systemic Corticosteroids Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Systemic Corticosteroids Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Systemic Corticosteroids Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Systemic Corticosteroids Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Methylprednisolone
Figure 10. Product Picture of Prednisolone
Figure 11. Product Picture of Betamethasone
Figure 12. Product Picture of Dexamethasone
Figure 13. Product Picture of Prednisone
Figure 14. Product Picture of Triamcinolone Acetonide
Figure 15. Product Picture of Hydrocortisone
Figure 16. Product Picture of Other
Figure 17. Global Systemic Corticosteroids Sales Market Share by Type in 2022
Figure 18. Global Systemic Corticosteroids Revenue Market Share by Type (2018-2023)
Figure 19. Systemic Corticosteroids Consumed in Hospital
Figure 20. Global Systemic Corticosteroids Market: Hospital (2018-2023) & (K Units)
Figure 21. Systemic Corticosteroids Consumed in Pharmacy
Figure 22. Global Systemic Corticosteroids Market: Pharmacy (2018-2023) & (K Units)
Figure 23. Systemic Corticosteroids Consumed in Other
Figure 24. Global Systemic Corticosteroids Market: Other (2018-2023) & (K Units)
Figure 25. Global Systemic Corticosteroids Sales Market Share by Application (2022)
Figure 26. Global Systemic Corticosteroids Revenue Market Share by Application in 2022
Figure 27. Systemic Corticosteroids Sales Market by Company in 2022 (K Units)
Figure 28. Global Systemic Corticosteroids Sales Market Share by Company in 2022
Figure 29. Systemic Corticosteroids Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Systemic Corticosteroids Revenue Market Share by Company in 2022
Figure 31. Global Systemic Corticosteroids Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Systemic Corticosteroids Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Systemic Corticosteroids Sales 2018-2023 (K Units)
Figure 34. Americas Systemic Corticosteroids Revenue 2018-2023 ($ Millions)
Figure 35. APAC Systemic Corticosteroids Sales 2018-2023 (K Units)
Figure 36. APAC Systemic Corticosteroids Revenue 2018-2023 ($ Millions)
Figure 37. Europe Systemic Corticosteroids Sales 2018-2023 (K Units)
Figure 38. Europe Systemic Corticosteroids Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Systemic Corticosteroids Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Systemic Corticosteroids Revenue 2018-2023 ($ Millions)
Figure 41. Americas Systemic Corticosteroids Sales Market Share by Country in 2022
Figure 42. Americas Systemic Corticosteroids Revenue Market Share by Country in 2022
Figure 43. Americas Systemic Corticosteroids Sales Market Share by Type (2018-2023)
Figure 44. Americas Systemic Corticosteroids Sales Market Share by Application (2018-2023)
Figure 45. United States Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Systemic Corticosteroids Sales Market Share by Region in 2022
Figure 50. APAC Systemic Corticosteroids Revenue Market Share by Regions in 2022
Figure 51. APAC Systemic Corticosteroids Sales Market Share by Type (2018-2023)
Figure 52. APAC Systemic Corticosteroids Sales Market Share by Application (2018-2023)
Figure 53. China Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Systemic Corticosteroids Sales Market Share by Country in 2022
Figure 61. Europe Systemic Corticosteroids Revenue Market Share by Country in 2022
Figure 62. Europe Systemic Corticosteroids Sales Market Share by Type (2018-2023)
Figure 63. Europe Systemic Corticosteroids Sales Market Share by Application (2018-2023)
Figure 64. Germany Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Systemic Corticosteroids Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Systemic Corticosteroids Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Systemic Corticosteroids Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Systemic Corticosteroids Sales Market Share by Application (2018-2023)
Figure 73. Egypt Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Systemic Corticosteroids Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Systemic Corticosteroids in 2022
Figure 79. Manufacturing Process Analysis of Systemic Corticosteroids
Figure 80. Industry Chain Structure of Systemic Corticosteroids
Figure 81. Channels of Distribution
Figure 82. Global Systemic Corticosteroids Sales Market Forecast by Region (2024-2029)
Figure 83. Global Systemic Corticosteroids Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Systemic Corticosteroids Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Systemic Corticosteroids Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Systemic Corticosteroids Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Systemic Corticosteroids Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の全身性コルチコステロイド市場予測 2023年-2029年] (コード:LP23DC00138)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全身性コルチコステロイド市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆